CAJ | 학술논문

抗肿瘤新生血管治疗是近年来兴起的一种治疗肿瘤的新模式,已经在相关肿瘤领域确立了一线治疗地位.随着抗肿瘤新生血管生成治疗在临床的广泛应用也逐步显露出它的一些局限性如耐药、治疗窗不明确、缺乏有效的生物标记物.我们可通过联合化疗、合理规律的化疗方案、抗血管生成拟态(VM)治疗等策略加以克服.
항종류신생혈관치료시근년래흥기적일충치료종류적신모식,이경재상관종류영역학립료일선치료지위.수착항종류신생혈관생성치료재림상적엄범응용야축보현로출타적일사국한성여내약、치료창불명학、결핍유효적생물표기물.아문가통과연합화료、합리규률적화료방안、항혈관생성의태(VM)치료등책략가이극복.
Anti-neoplasic angiogenesis therapy is a rising new treatment model for cancer in recent years, and it has been established the status of first-line treatment in the relevant anti-neoplasic fields. With the extensive clinical applications, the anti-neoplasic angiogenesis therapy have gradually showed some of its limitations and shortcomings,such as drug resistance, uncertain therapeutic window, lack of effective biomarkers, et al. However, we can overcome these disadvantages through combined chemotherapy, reasonable chemotherapy protocols and anti-VM therapy.